Published in January 2026, the AHA-ASA's acute ischemic stroke care guidelines replace those previously issued in 2018.

Thunderbolt, a computer-assisted thrombectomy device meant to address distal occlusions in patients with acute ischemic ...

MICOT PHARMA-B (02335.HK) +0.380 (+0.890%) announced that the Phase Ib/II clinical trial of the group's self-developed ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal ...

Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centers, women with large vessel occlusion acute ischemic stroke are less likely than men to be ...

Hourly heat exposure is associated with an increased risk for acute ischemic stroke (AIS) onset, according to a study published online Feb. 28 in JAMA Network Open. Xinlei Zhu, from Fudan University ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

Penumbra expands clinical research through the FORWARD stroke study while remaining part of the NYSE Composite with advanced ...